Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer

Vasen HFA, Haites NE, Evans DGR et al (1998) Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 european family cancer clinics. Eur J Cancer 34:1922–1926

Brekelmans CT, Seynaeve C, Bartels CC et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924–930

Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260–1268

Komenaka IK, Ditkoff BA, Joseph KA et al (2004) The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079–2083

Kriege M, Brekelmans CT, Boetes C et al (2001) MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch national study (MRISC). Fam Cancer 1:163–168

Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437

Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317–1325

Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778

Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476

Litherland JC, Stallard S, Hole D et al (1999) The effect of hormone replacement therapy on the sensitivity of screening mammograms. Clin Radiol 54:285–288

Kerlikowske K, Grady D, Barclay J et al (1996) Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276:33–38

Rosenberg RD, Hunt WC, Williamson MR et al (1998) Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 209:511–518

Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165–175

Tabar L, Fagerberg G, Chen HH et al (1995) Efficacy of breast cancer screening by age. New results from the Swedish two-county trial. Cancer 75:2507–2517

Fletcher SW, Black W, Harris R et al (1993) Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85:1644–1656

Carney PA, Miglioretti DL, Yankaskas BC et al (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138:168–175

Ciatto S, Visioli C, Paci E et al (2004) Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer 90:393–396

Saarenmaa I, Salminen T, Geiger U et al (2001) The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultasonography. Breast Cancer Res Treat 67:117–123

Banks E, Reeves G, Beral V et al (2004) Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. Br Med J 329:477

Tilanus-Linthorst M, Verhoog L, Obdeijn IM et al (2002) A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. Int J Cancer 102:91–95

Halapy E, Chiarelli AM, Klar N et al (2005) Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancer. Breast Cancer Res Treat 90:299–305

van Gils CH, Otten JD, Verbeek AL et al (1998) Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, the Netherlands. J Epidemiol Commun Health 52:267–271

Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 92:1081–1087

Kavanagh AM, Mitchell H, Giles GG (2000) Hormone replacement therapy and accuracy of mammographic screening. Lancet 355:270–274

Blanks RG, Moss SM, McGahan CE et al (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990–8: comparison of observed with predicted mortality. Br Med J 321:665–669

Kavanagh AM, Cawson J, Byrnes GB et al (2005) Hormone replacement therapy, percent mammographic density, and sensitivity of mammography. Cancer Epidemiol Biomarkers Prev 14:1060–1064

Thurfjell EL, Holmberg LH, Persson IR (1997) Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 203:339–341

Sardanelli F, Giuseppetti GM, Panizza P et al (2004) Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 183:1149–1157

Bluemke DA, Gatsonis CA, Chen MH et al (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735–2742

Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849

Harms SE (1998) Breast magnetic resonance imaging. Semin Ultrasound CT MR 19:104–120

Heywang-Kobrunner SH, Viehweg P, Heinig A et al (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94–108

Kinkel K, Hylton NM (2001) Challenges to interpretation of breast MRI. J Magn Reson Imaging 13:821–829

Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144

Muller-Schimpfle M, Ohmenhauser K, Stoll P et al (1997) Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology 203:145–149

Claus EB, Risch NJ, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Cancer 73:643–651

American College of Radiology (1995) Illustrated breast imaging reporting and data system (BI-RADS). 3

Berg WA, Campassi C, Langenberg P et al (2000) Breast imaging reporting and data system: inter- and intraobserver variability in feature analysis and final assessment. AJR Am J Roentgenol 174:1769–1777

Lee-Han H, Cooke G, Boyd NF (1995) Quantitative evaluation of mammographic densities: a comparison of methods of assessment. Eur J Cancer Prev 4:285–292

Sivaramakrishna R, Obuchowski NA, Chilcote WA et al (2001) Automatic segmentation of mammographic density. Acad Radiol 8:250–256

Ooms EA, Zonderland HM, Eijkemans MJC et al (2006) Mammography: inter-observer variability in breast density assesment (abstract). Fifth international meeting: endocrine treatment prevention of breast ABD gynaecological cancers

Kaas R, Kroger R, Hendriks JH et al (2004) The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers. Eur Radiol 14: 1647–1653

Buist DS, Porter PL, Lehman C et al (2004) Factors contributing to mammography failure in women aged 40–49 years. J Natl Cancer Inst 96:1432–1440

Tilanus-Linthorst MM, Kriege M, Boetes C et al (2005) Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 41:1610–1617

Day NE, Williams DR, Khaw KT (1989) Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59:954–958

Kriege M, Brekelmans CTM, Boetes C et al (2006, in press) Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer

Adem C, Reynolds C, Soderberg CL et al (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97:1–11